Beximco Pharmaceuticals (LON:BXP) Stock Passes Above 50-Day Moving Average - Time to Sell?

Key Points

• Beximco Pharmaceuticals' shares have risen above their 50-day moving average, indicating a potentially positive trend in stock performance.
• The stock was last traded at GBX 49.60 ($0.67), with a market capitalization of £35.07 billion and a P/E ratio of 5.52.
• Beximco Pharmaceuticals, established in 1976, is a leading manufacturer and exporter of medicines based in Bangladesh, expanding its operations from importing to manufacturing over the years.

Shares of Beximco Pharmaceuticals Limited (LON:BXP - Get Free Report) crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 41.03 ($0.55) and traded as high as GBX 50 ($0.68). Beximco Pharmaceuticals shares last traded at GBX 49.60 ($0.67), with a volume of 6,942 shares changing hands.

Beximco Pharmaceuticals Trading Up 0.8%

The company has a market cap of £209.09 million, a price-to-earnings ratio of 3.29 and a beta of 0.61. The company has a quick ratio of 0.37, a current ratio of 2.13 and a debt-to-equity ratio of 12.47. The company's 50-day moving average is GBX 41.83 and its 200 day moving average is GBX 39.13.

Beximco Pharmaceuticals Company Profile

Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands.